GLOBE PHARMA ApS: Financial statements 2018
CVR: 36493119
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
GLOBE PHARMA ApS (CVR 36493119) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 725,258 and a net result of DKK 546,994 compared with DKK 513,489 the year before. That is an increase of 7.1% compared with the year before. Equity in the 2018 report amounted to DKK 597,436. The solvency ratio was 32.4%.
- Gross Profit
- DKK 725,258
- Profit/Loss
- DKK 546,994
- Equity
- DKK 597,436
- Total Assets
- DKK 1,842,856
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 725 t. | 547 t. | 597 t. | - |
| 2017 | - | 677 t. | 513 t. | 296 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 27, 2018, REVISIONSFIRMAET WOIREMOSE & PARTNER REGISTRERET REVISIONSANPARTSSELSKAB has stepped down as auditor of GLOBE PHARMA ApS.
About GLOBE PHARMA ApS
GLOBE PHARMA ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Ravn. The company is owned by RAVNEN HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,623,545 and a net result of DKK 460,318 compared with DKK 738,896 the year before. Equity in the 2025 report amounted to DKK 511,882.